iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ITOS iTeos Therapeutics

未开盘 07-08 16:00:00 EDT

10.12

+0.05

+0.50%

盘后10.12

+0.000.00%

16:56 EDT

最高10.17	最低10.08	成交量43.49万
今开10.12	昨收10.07	日振幅0.89%
总市值3.87亿	流通市值2.24亿	总股本3,827万
成交额440.40万	换手率1.97%	流通股本2,210万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ITOS","market":"US","secType":"STK","nameCN":"iTeos Therapeutics","latestPrice":10.12,"timestamp":1752004800000,"preClose":10.07,"halted":0,"volume":434852,"hourTrading":{"tag":"盘后","latestPrice":10.12,"preClose":10.12,"latestTime":"16:56 EDT","volume":13855,"amount":140212.7886,"timestamp":1752008215425},"delay":0,"floatShares":22095909,"shares":38273795,"eps":-3.090709,"marketStatus":"未开盘","change":0.05,"latestTime":"07-08 16:00:00 EDT","open":10.12,"high":10.17,"low":10.08,"amount":4404025.813836,"amplitude":0.008937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.090709,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752048000000},"marketStatusCode":0,"adr":0,"listingDate":1595563200000,"exchange":"NASDAQ","adjPreClose":10.07,"preHourTrading":{"tag":"盘前","latestPrice":10.11,"preClose":10.07,"latestTime":"09:29 EDT","volume":935,"amount":9448.0791625,"timestamp":1751981392060},"postHourTrading":{"tag":"盘后","latestPrice":10.12,"preClose":10.12,"latestTime":"16:56 EDT","volume":13855,"amount":140212.7886,"timestamp":1752008215425},"volumeRatio":0.709586,"impliedVol":0.8954,"impliedVolPercentile":0.712},"requestUrl":"/m/hq/s/ITOS","defaultTab":"news","newsList":[{"id":"2539269071","title":"iTeos Therapeutics与GSK价值20亿美元的TIGIT合作未达预期后将关闭公司iTeos Therapeutics to Shut Down After $2 Billion TIGIT Collaboration with GSK Falls Short","url":"https://stock-news.laohu8.com/highlight/detail?id=2539269071","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539269071?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:06","pubTimestamp":1748527560,"startTime":"0","endTime":"0","summary":"The shutdown marks a significant development for iTeos, which had focused on advancing immuno-oncology therapies. The company partnered with GSK in 2021 to develop EOS-448, an anti-TIGIT monoclonal antibody designed to enhance immune system responses against cancer. Despite initial optimism surrounding the program, results failed to demonstrate sufficient efficacy or commercial viability.这一关闭标志着iTeos的一项重大进展，该公司此前专注于推进免疫肿瘤学疗法。2021年，该公司与GSK合作开发EOS-448，这是一种旨在增强免疫系统对癌症反应的抗TIGIT单克隆抗体。As part of its closure process, iTeos will prioritize shareholder payouts and seek buyers for its remaining pipeline assets..作为其关闭过程的一部分，iTeos将优先考虑股东分红，并为其剩余的管线资产寻找买家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292208329769ea15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292208329769ea15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ITOS","BK4539","GSK","BK4007","BK4532","LU1829250122.USD","LENZ","GSK.UK","BK4139","BK4588"],"gpt_icon":0},{"id":"2538477552","title":"富国银行：下调ITeos Therapeutics(ITOS.US)评级，由增持调整至持股观望评级, 目标价由13.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538477552","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538477552?lang=zh_cn&edition=full","pubTime":"2025-05-28 23:02","pubTimestamp":1748444568,"startTime":"0","endTime":"0","summary":"富国银行：下调ITeos Therapeutics(ITOS.US)评级，由增持调整至持股观望评级, 目标价由13.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/28230250725669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2537210639","title":"Iteos Therapeutics, Inc.盘中异动 下午盘股价大涨5.11%报8.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537210639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537210639?lang=zh_cn&edition=full","pubTime":"2025-05-23 03:11","pubTimestamp":1747941102,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日03时11分，Iteos Therapeutics, Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报8.64美元/股，成交量155.681万股，换手率4.07%，振幅5.72%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Vigil Neuroscience, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Instil Bio, Inc.涨幅较大，Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为5246.80%、2410.50%、1180.34%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为124.89%、71.77%、70.15%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052303114297624cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052303114297624cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITOS","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2536687477","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.25%报8.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687477?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:31","pubTimestamp":1747661509,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时31分，Iteos Therapeutics, Inc.股票出现波动，股价大幅拉升5.25%。截至发稿，该股报8.22美元/股，成交量4.4411万股，换手率0.12%，振幅1.09%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为6967.19%、4280.76%、1962.01%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、再鼎医药、Generation Bio Co.，振幅分别为218.87%、105.85%、104.90%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213149aa2c9261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213149aa2c9261&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ITOS","BK4539"],"gpt_icon":0},{"id":"2535820637","title":"Iteos Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报7.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535820637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535820637?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:47","pubTimestamp":1747320479,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时47分，Iteos Therapeutics, Inc.股票出现异动，股价快速拉升5.00%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。消息层面，截至22时47分，《Piper Sandler：维持ITeos Therapeutics评级，由增持调整至增持评级, 目标价由16.00美元调整至12.00美元。》资讯为影响Iteos Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224759a6e07f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224759a6e07f4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","ITOS","BK4139"],"gpt_icon":0},{"id":"2535091077","title":"Piper Sandler：维持ITeos Therapeutics评级，由增持调整至增持评级, 目标价由16.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535091077","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535091077?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:15","pubTimestamp":1747239310,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持ITeos Therapeutics(ITOS.US)评级，由增持调整至增持评级, 目标价由16.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500175894f6e779&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500175894f6e779&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2535707073","title":"Iteos Therapeutics, Inc.盘中异动 早盘快速下跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535707073?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:07","pubTimestamp":1747231625,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时07分，Iteos Therapeutics, Inc.股票出现波动，股价快速下跌5.10%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。消息层面，截至22时07分，《小摩：下调ITeos Therapeutics评级，由增持调整至中性评级, 目标价由15.00美元调整至8.00美元。》资讯为影响Iteos Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514220706a6df1120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514220706a6df1120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ITOS","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2535190026","title":"Leerink Partners：下调ITeos Therapeutics(ITOS.US)评级，由优于大市调整至大市一致评级, 目标价由47.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535190026","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535190026?lang=zh_cn&edition=full","pubTime":"2025-05-14 20:07","pubTimestamp":1747224473,"startTime":"0","endTime":"0","summary":"Leerink Partners：下调ITeos Therapeutics(ITOS.US)评级，由优于大市调整至大市一致评级, 目标价由47.00美元调整至9.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14200750390571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2535035536","title":"小摩：下调ITeos Therapeutics评级，由增持调整至中性评级, 目标价由15.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535035536","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535035536?lang=zh_cn&edition=full","pubTime":"2025-05-14 05:54","pubTimestamp":1747173293,"startTime":"0","endTime":"0","summary":"小摩：下调ITeos Therapeutics(ITOS.US)评级，由增持调整至中性评级, 目标价由15.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051405590194f5f641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051405590194f5f641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2535774881","title":"Iteos Therapeutics, Inc.股价上涨21.75% 市值涨7013.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535774881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535774881?lang=zh_cn&edition=full","pubTime":"2025-05-13 21:31","pubTimestamp":1747143097,"startTime":"0","endTime":"0","summary":"北京时间2025年05月13日21时31分，Iteos Therapeutics, Inc.股票出现波动，股价急速上涨21.75%。截至发稿，该股报8.43美元/股，成交量301.725万股，换手率7.88%，振幅1.45%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Hcw Biologics Inc.、Cns Pharmaceuticals, Inc.、Humacyte, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Hcw Biologics Inc.、Polyrizon Ltd.较为活跃，换手率分别为1863.14%、1141.09%、935.61%，振幅较大的相关个股有Hcw Biologics Inc.、Cns Pharmaceuticals, Inc.、Humacyte, Inc.，振幅分别为43.18%、23.13%、13.26%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513213137a6dda028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513213137a6dda028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2534757279","title":"Iteos Therapeutics, Inc.盘中异动 快速拉升5.33%报7.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534757279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534757279?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:34","pubTimestamp":1747056889,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时34分，Iteos Therapeutics, Inc.股票出现异动，股价急速拉升5.33%。截至发稿，该股报7.02美元/股，成交量5250股，换手率0.01%，振幅0.75%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Cytomx Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、艾吉纳斯涨幅较大，Nucana Plc、Cytomx Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为318.85%、68.03%、59.13%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Engene Holdings Inc.、艾吉纳斯，振幅分别为32.31%、21.28%、17.18%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221344994f4824f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221344994f4824f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","ITOS"],"gpt_icon":0},{"id":"2533580493","title":"Iteos Therapeutics, Inc.盘中异动 早盘快速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533580493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533580493?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:55","pubTimestamp":1746453315,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时55分，Iteos Therapeutics, Inc.股票出现异动，股价快速下挫5.28%。截至发稿，该股报7.36美元/股，成交量1.4302万股，换手率0.04%，振幅4.25%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Nucana Plc、Scisparc Ltd.、Polyrizon Ltd.较为活跃，换手率分别为786.08%、454.43%、59.01%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Scisparc Ltd.、Nucana Plc，振幅分别为113.27%、43.94%、38.70%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505215515974fa547&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505215515974fa547&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527486784","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527486784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527486784?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:45","pubTimestamp":1744724703,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时45分，Iteos Therapeutics, Inc.股票出现异动，股价大幅上涨5.42%。截至发稿，该股报5.83美元/股，成交量1.4361万股，换手率0.04%，振幅4.88%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为530.35%、213.66%、84.67%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.，振幅分别为80.08%、66.02%、38.78%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152145039738a8fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152145039738a8fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ITOS","BK4007"],"gpt_icon":0},{"id":"2518289739","title":"Iteos Therapeutics, Inc.2024财年实现净利润-1.34亿美元，同比减少18.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289739?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536046,"startTime":"0","endTime":"0","summary":"3月10日，Iteos Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.34亿美元，同比减少18.58%；其中营业收入为35.00百万美元，同比增加177.78%，每股基本收益为-3.32美元。从资产负债表来看，Iteos Therapeutics, Inc.总负债96.68百万美元，其中短期债务1.34百万美元，资产负债比为0.08，流动比率为0.13。机构评级：截至2025年3月10日，当前有5家机构对Iteos Therapeutics, Inc.目标价做出预测，其中目标均价为18.80美元，其中最低目标价为15.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a2689809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000113a2689809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2517194167","title":"小摩：维持ITeos Therapeutics(ITOS.US)评级，由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194167","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194167?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:25","pubTimestamp":1741278312,"startTime":"0","endTime":"0","summary":"小摩：维持ITeos Therapeutics(ITOS.US)评级，由增持调整至增持评级, 目标价由22.00美元调整至15.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07002548577309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ITOS","LENZ"],"gpt_icon":0},{"id":"2517940504","title":"Iteos Therapeutics, Inc.盘中异动 股价大涨5.04%报7.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940504?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:06","pubTimestamp":1741198006,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时06分，Iteos Therapeutics, Inc.股票出现异动，股价急速拉升5.04%。截至发稿，该股报7.20美元/股，成交量17.06万股，换手率0.47%，振幅5.55%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为946.28%、305.29%、299.42%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020646989d753b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306020646989d753b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ","BK4139"],"gpt_icon":0},{"id":"1153201753","title":"ITeos Therapeutics 2024年第4季度 GAAP每股收益$(1.01) 超过$(1.06) 预期，2024年12月31日现金和投资余额为6.55亿美元，预计可支撑至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1153201753","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153201753?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:14","pubTimestamp":1741176886,"startTime":"0","endTime":"0","summary":"ITeos Therapeutics  报告其季度亏损为每股$，这比分析师普遍预期的$高出4.72%。与去年同期每股亏损$相比，这一数字下降了18.82%。以上内容来自Benzinga Earnings专栏，原文如下：ITeos $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 4.72 percent. This is a 18.82 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ITOS"],"gpt_icon":0},{"id":"2516371110","title":"Iteos Therapeutics, Inc.盘中异动 临近午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516371110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516371110?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:33","pubTimestamp":1740760400,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时33分，Iteos Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报7.35美元/股，成交量26.746万股，换手率0.73%，振幅5.57%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2886.07%、489.39%、363.32%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、46.60%、43.95%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003320abe10752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003320abe10752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITOS","LENZ"],"gpt_icon":0},{"id":"2507180674","title":"Iteos Therapeutics, Inc.盘中异动 下午盘股价大涨5.07%报7.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507180674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507180674?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:59","pubTimestamp":1738263592,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时59分，Iteos Therapeutics, Inc.股票出现波动，股价快速拉升5.07%。截至发稿，该股报7.87美元/股，成交量8.4172万股，换手率0.23%，振幅5.87%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1780.26%、295.39%、237.78%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025953abbd79b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025953abbd79b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ITOS","LENZ","BK4139"],"gpt_icon":0},{"id":"2503528642","title":"Iteos Therapeutics, Inc.盘中异动 早盘股价大涨5.61%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503528642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503528642?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951533,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Iteos Therapeutics, Inc.股票出现异动，股价大幅拉升5.61%。截至发稿，该股报8.09美元/股，成交量9647股，换手率0.03%，振幅2.09%。Iteos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.03%、52.76%、35.39%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为12.28%、12.00%、10.72%。Iteos Therapeutics, Inc.公司简介：ITeos Therapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232149604b412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232149604b412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ITOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iteostherapeutics.com","stockEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.8776},{"period":"6month","weight":0.2958},{"period":"1year","weight":-0.3097},{"period":"ytd","weight":0.3177}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iTeos Therapeutics, Inc.根据特拉华州法律于2019年10月4日成立。该公司是临床阶段的生物制药公司，率先发现和开发了面向患者的新一代高度分化的免疫肿瘤疗法。该公司利用他们对肿瘤微环境和免疫抑制途径的深刻理解来设计新的候选药物，目的是提高肿瘤治疗的临床疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.061341},{"month":2,"riseRate":0.4,"avgChangeRate":0.034522},{"month":3,"riseRate":0.2,"avgChangeRate":-0.084583},{"month":4,"riseRate":0.4,"avgChangeRate":-0.094285},{"month":5,"riseRate":0.6,"avgChangeRate":0.130987},{"month":6,"riseRate":0.4,"avgChangeRate":0.024141},{"month":7,"riseRate":0.8,"avgChangeRate":0.077302},{"month":8,"riseRate":0.4,"avgChangeRate":0.075236},{"month":9,"riseRate":0,"avgChangeRate":-0.164906},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063472},{"month":11,"riseRate":0.8,"avgChangeRate":0.094564},{"month":12,"riseRate":0.6,"avgChangeRate":0.123748}],"exchange":"NASDAQ","name":"iTeos Therapeutics","nameEN":"iTeos Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iTeos Therapeutics,ITOS,iTeos Therapeutics股票,iTeos Therapeutics股票老虎,iTeos Therapeutics股票老虎国际,iTeos Therapeutics行情,iTeos Therapeutics股票行情,iTeos Therapeutics股价,iTeos Therapeutics股市,iTeos Therapeutics股票价格,iTeos Therapeutics股票交易,iTeos Therapeutics股票购买,iTeos Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iTeos Therapeutics(ITOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iTeos Therapeutics(ITOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}